Sensitization of amphetamine-induced stereotyped behaviors during the acute response: Role of D1 and D2 dopamine receptors

Brain Research

Volumn 822, Issue 1-2, 1999, Pages 164-174

  Kuczenski, Ronald ^a   Segal, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Binge; Dopamine receptor; Quinpirole; SKF 82958; Stereotypy

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; DRUG ABUSE; DRUG RECEPTOR BINDING; DRUG RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; STEREOTYPY;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; BRAIN CHEMISTRY; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; LOCOMOTION; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR;

EID: 0033586281     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01149-X     Document Type: Article

References (28)

1. P.H. Andersen, J. Jansen, Dopamine receptor agonists: selectivity and dopamine receptor efficacy, Eur. J. Pharmacol. 188 (1990) 335-347.
2. J. Arnt, Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity, Naunyn-Schmiedeberg's Arch. Pharmacol. 330 (1985) 97-104.
3. J. Arnt, J. Hyttel, J. Perregaard, Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats, Eur. J. Pharmacol. 133 (1987) 137-145.
4. 2 dopamine agonists in intact rats, Brain Res. 504 (1989) 276-283.
5. A.R. Braun, T.N. Chase, Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors, Eur. J. Pharmacol. 131 (1986) 301-306.
6. E. Carboni, A. Imperato, L. Perezzani, G. Di Chiara, Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats, Neuroscience 28 (1989) 653-661.
7. I. Creese, R. Kuczenski, D.S. Segal, Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock, Pharmacol. Biochem. Behav. 17 (1982) 375-376.
8. 2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum, Neuroscience 39 (1990) 59-67.
9. R. Kuczenski, W.P. Melega, A.K. Cho, D.S. Segal, Extracellular dopamine and amphetamine following systemic amphetamine administration: comparison to the behavioral response, J. Pharmacol. Exp. Ther. 282 (1997) 591-596.
10. R. Kuczenski, D.S. Segal, Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis, J. Neurosci. 9 (1989) 2051-2065.
11. R. Kuczenski, D.S. Segal, Sensitization of amphetamine-induced stereotyped behaviors during the acute response, J. Pharmacol. Exp. Ther. 288 (1998) 699-709.
12. R. Kuczenski, D.S. Segal, M.L. Aizenstein, Amphetamine, fencamfamine, and cocaine: relationships between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics, J. Neurosci. 11 (1991) 2703-2712.
13. R. Kuczenski, D.S. Segal, L.D. Manley, Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates, J. Neurochem. 54 (1990) 1492-1499.
14. 3H]quinperole binding to the D,-like dopamine receptors in rat brain, J. Pharmacol. Exp. Ther. 262 (1992) 929-935.
15. 1 agonist SKF 38393, Neuropharmacology 25 (1986) 947-949.
16. A. Molloy, K.M. O'Boyle, M.T. Pugh, J.L. Waddington, Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists, Pharmacol. Biochem. Behav. 25 (1986) 249-253.
17. E.J. Nestler, Molecular mechanisms of opiate and cocaine addiction, Curr. Opin. Neurobiol. 7 (5) (1997) 713-719.
18. 1 dopamine receptor, Neuropharmacology 28 (1989) 401-405.
19. F.S. Radhakishun, J.M. van Ree, The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens, Eur. J. Pharmacol. 136 (1987) 41-47.
20. T.E. Robinson, D.M. Camp, Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats?, Neuropsychopharmacol 3 (1990) 163-173.
21. 3H]quinperole, Eur. J. Pharmacol. 203 (1991) 105-109.
22. D.S. Segal, R. Kuczenski, Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates, J. Pharmacol. Exp. Ther. 242 (1987) 917-926.
23. D.S. Segal, R. Kuczenski, Behavioral pharmacology of amphetamine, in: A.K. Cho, D.S. Segal (Eds.), Amphetamine and its Analogues: Psychopharmacology, Toxicology and Abuse, Vol. 4, Academic Press, San Diego, 1994, pp. 115-150.
24. D.S. Segal, R. Kuczenski, Escalating dose/binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen/nucleus accumbens dopamine responses, Psychopharmacology (1998).
25. D.W. Self, E.J. Nestler, Molecular mechanisms of drug reinforcement and addiction, Annu. Rev. Neurosci. 18 (1995) 463-495.
26. T. Sharp, T. Zetterstrom, T. Ljungberg, U. Ungerstedt, A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis, Brain Res. 401 (1987) 322-330.
27. 3 receptors, Neuropharmacology 36 (1997) 787-792.
28. K. Tsurata, E.A. Frey, C.W. Grewe, T.E. Cote, R.L. Eskay, J.W. Kebabian, Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor, Nature 292 (1981) 463-465.